StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) stock

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$429.90+0.42 (+0.10%)

Close on Nov 12, 2026Market cap $92.88BP/E 18.3Yield –

Elevance Health, Inc. grew revenue 3.6% to $201.83B over the twelve months to Sep 30, 2026. Operating income fell 28.2% to $5.43B, moving the operating margin from 3.9% to 2.7%. Free cash flow was $6.51B, up 72.9% from a year earlier. At the latest close the market valued the company at $92.88B, 18.3 times its earnings.

Revenue
$201.83B
+3.6% vs. a year earlier
Operating income
$5.43B
-28.2% vs. a year earlier
Free cash flow
$6.51B
+72.9% vs. a year earlier
EPS, diluted
$23.45
-4.1% vs. a year earlier

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$92.88B
P/E ratio
18.3
Price to sales
0.46
Price to book
2.08
Dividend yield
–
Free cash flow yield
7.01%

Fundamentals

Revenue
$201.83B
Net income
$5.14B
EPS, diluted
$23.45
Free cash flow
$6.51B
Book value per share
$205.34
Diluted shares
218M

Trading

Next earnings
Jan 27, 2027 (estimated, before the open)
Previous close
$429.48
Open
$433.78
Day's range
$427.13 – $435.00
Volume
943,191
Average volume (20 days)
1,383,341
Index membership
S&P 500, Russell 1000, Russell 3000
Beta (5 years)
0.45
52-week range
$274.84 – $450.69
RSI (14 days)
55.1
Volatility (1 year)
34.8%
Relative volume
0.75×
WACC
6.5%

On 2 of our idea lists: Buyback cannibals, Superinvestor favorites

Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2009, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodELVS&P 500DifferenceELV per yearS&P 500 per year
1 month+1.9%-2.7%+4.5 pts
3 months+8.2%-1.7%+9.9 pts
Year to date+24.4%+11.9%+12.5 pts
1 year+33.8%+12.0%+21.8 pts
3 years-1.4%+78.2%−79.5 pts-0.5%+21.2%
5 years+5.8%+73.2%−67.4 pts+1.1%+11.6%
10 years+269.1%+309.6%−40.6 pts+13.9%+15.1%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$201.83B+3.6% YoY

Gross profit

$179.71B+3.8% YoY

Operating income

$5.43B-28.2% YoY

Net income

$5.14B-7.1% YoY

EPS, diluted

$23.45-4.1% YoY

Free cash flow

$6.51B+72.9% YoY
Reported periodTrailing twelve months

Press releases

Releases Elevance Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. E A R N I N G S R E L E A S E
    Results
  2. E A R N I N G S R E L E A S E
    Results
  3. E A R N I N G S R E L E A S E
    Results
  4. Elevance Health Announces Management Changes; CFO Mark Kaye to Expand Responsibilities to Include Carelon and Felicia Norwood to Lead Consolidated Health Benefits Organization
    Update
  5. E A R N I N G S R E L E A S E
    Results
  6. N I N G S R E L E A S E
    Results
All press releases and earnings

About Elevance Health

Hospital & Medical Service Plans

Elevance Health delivers integrated health solutions spanning medical, pharmacy, and behavioral health services. The enterprise operates across four primary segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. Product offerings include risk-based network plans like PPOs and HMOs, fee-based administrative solutions, pharmacy management, and specialty options such as dental, vision, stop loss, and supplemental coverage. Customers include individual consumers, small and large employer groups, and participants in federal and state-sponsored Medicare and Medicaid programs.

Company profile, executives and history

Elevance Health stock: common questions

What is Elevance Health's stock price?

ELV closed at $429.90 on Nov 12, 2026, up 0.10% on the day. Over the past 52 weeks it traded between $274.84 and $450.69.

What is Elevance Health's market cap?

Elevance Health was worth $92.88B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.

What is ELV's P/E ratio?

ELV trades at 18.3 times earnings, based on diluted earnings per share of $23.45 over the twelve months to Sep 30, 2026.

How much revenue does Elevance Health make?

Elevance Health reported revenue of $201.83B for the twelve months to Sep 30, 2026, up 3.6% from a year earlier.

Does Elevance Health pay a dividend?

No. Elevance Health has not paid a cash dividend over the last twelve months.

When does Elevance Health report earnings next?

Elevance Health is expected to report Q4 FY2026 results on Jan 27, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.

How has ELV stock performed over the past year?

Including dividends, ELV returned +33.8% over the past year, against +12.0% for the S&P 500.

How many ELV shares are sold short?

5M shares were sold short at the latest FINRA report, 2.11% of the float, or 3.3 days of average trading volume.

Who are Elevance Health's competitors?

Companies most similar to Elevance Health by business, industry and size include CNC, CI, HUM, UNH, MOH.

See a number that looks wrong?